Australia Infections Imaging Market Report Size, Share, Growth Drivers, Trends, Opportunities And Forecast 2025–2030

The Australia Infections Imaging Market, worth USD 1.2 Bn, grows due to increasing disease prevalence, AI-enhanced imaging, and urban healthcare infrastructure in Sydney, Melbourne, and Brisbane.

Region:Global

Author(s):Geetanshi

Product Code:KRAE1298

Pages:96

Published On:February 2026

About the Report

Base Year 2024

Australia Infections Imaging Market Overview

  • The Australia Infections Imaging Market is valued at USD 1.2 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of infectious diseases, advancements in imaging technologies, and the rising demand for early diagnosis and treatment. The integration of artificial intelligence in imaging systems has further enhanced diagnostic accuracy, contributing to market expansion.
  • Key cities such as Sydney, Melbourne, and Brisbane dominate the market due to their advanced healthcare infrastructure, high population density, and significant investments in medical technology. These urban centers are home to leading hospitals and diagnostic centers, which facilitate the adoption of innovative imaging solutions, thereby driving market growth.
  • In 2023, the Australian government implemented the National Health Reform Agreement, which emphasizes the importance of early detection and treatment of infectious diseases. This regulation allocates AUD 2 billion to enhance diagnostic imaging services across the country, aiming to improve healthcare outcomes and accessibility for patients.
Australia Infections Imaging Market Size

Australia Infections Imaging Market Segmentation

By Type:The market is segmented into various imaging types, including X-ray Imaging, MRI Imaging, CT Scans, Ultrasound Imaging, PET Scans, Nuclear Medicine Imaging, and Others. Among these, X-ray Imaging and MRI Imaging are the most widely used due to their effectiveness in diagnosing a range of infectious diseases. The demand for advanced imaging technologies is increasing, driven by the need for accurate and timely diagnosis.

Australia Infections Imaging Market segmentation by Type.

By End-User:The end-user segmentation includes Hospitals, Diagnostic Imaging Centers, Research Institutions, Outpatient Facilities, and Others. Hospitals are the leading end-users, as they require advanced imaging technologies for patient diagnosis and treatment. The increasing number of hospitals and healthcare facilities in urban areas is driving the demand for imaging services.

Australia Infections Imaging Market segmentation by End-User.

Australia Infections Imaging Market Competitive Landscape

The Australia Infections Imaging Market is characterized by a dynamic mix of regional and international players. Leading participants such as Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Fujifilm Medical Systems, Hitachi Medical Corporation, Agfa HealthCare, Carestream Health, Hologic, Inc., Mindray Medical International Limited, Varian Medical Systems, Toshiba Medical Systems, Samsung Medison, Bracco Imaging, Neusoft Medical Systems contribute to innovation, geographic expansion, and service delivery in this space.

Siemens Healthineers

1847

Germany

GE Healthcare

1892

USA

Philips Healthcare

1891

Netherlands

Canon Medical Systems

1930

Japan

Fujifilm Medical Systems

1934

Japan

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Innovation Rate

Australia Infections Imaging Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Infectious Diseases:The rise in infectious diseases in Australia, with over 1.5 million reported cases annually, is a significant growth driver for the infections imaging market. The Australian Institute of Health and Welfare reported that hospitalizations due to infectious diseases have increased by 10% over the past five years. This growing burden necessitates advanced imaging solutions for accurate diagnosis and treatment, thereby boosting market demand.
  • Advancements in Imaging Technology:The Australian imaging market is witnessing rapid technological advancements, with investments exceeding AUD 500 million in the future. Innovations such as high-resolution MRI and CT scans enhance diagnostic accuracy, leading to better patient outcomes. The integration of digital imaging technologies is expected to improve workflow efficiency in healthcare facilities, further driving the adoption of advanced imaging solutions across the country.
  • Rising Healthcare Expenditure:Australia's healthcare expenditure is projected to reach AUD 200 billion in the future, reflecting a 5% annual increase. This rise in spending is primarily directed towards improving healthcare infrastructure and technology, including imaging services. As hospitals and clinics allocate more resources to diagnostic imaging, the demand for advanced imaging equipment and services is expected to grow significantly, supporting market expansion.

Market Challenges

  • High Cost of Imaging Equipment:The cost of advanced imaging equipment, such as MRI machines, can exceed AUD 3 million, posing a significant barrier for healthcare providers. Many facilities struggle to justify these capital expenditures, especially in a competitive market. This financial strain can limit the availability of cutting-edge imaging technologies, hindering the overall growth of the infections imaging market in Australia.
  • Limited Access in Rural Areas:Approximately 30% of Australia's population resides in rural areas, where access to advanced imaging services is severely limited. Many rural healthcare facilities lack the necessary equipment and trained personnel, leading to disparities in healthcare delivery. This challenge restricts the overall market potential, as patients in these regions may face delays in diagnosis and treatment for infectious diseases.

Australia Infections Imaging Market Future Outlook

The future of the infections imaging market in Australia appears promising, driven by technological advancements and increasing healthcare investments. The integration of artificial intelligence in imaging processes is expected to enhance diagnostic accuracy and efficiency. Additionally, the expansion of telemedicine will facilitate remote consultations, improving access to imaging services for patients in underserved areas. These trends indicate a robust growth trajectory for the market, addressing current challenges while capitalizing on emerging opportunities.

Market Opportunities

  • Expansion of Telemedicine:The telemedicine sector in Australia is projected to grow to AUD 1.5 billion in the future, providing a significant opportunity for the infections imaging market. By integrating imaging services with telehealth platforms, healthcare providers can enhance patient access to diagnostic services, particularly in remote areas, thereby driving market growth.
  • Development of Portable Imaging Devices:The demand for portable imaging devices is on the rise, with the market expected to reach AUD 300 million in the future. These devices offer flexibility and accessibility, particularly in emergency and rural settings. Their development can significantly improve the speed and efficiency of diagnosing infectious diseases, creating a substantial opportunity for market players.

Scope of the Report

SegmentSub-Segments
By Type

X-ray Imaging

MRI Imaging

CT Scans

Ultrasound Imaging

PET Scans

Nuclear Medicine Imaging

Others

By End-User

Hospitals

Diagnostic Imaging Centers

Research Institutions

Outpatient Facilities

Others

By Application

Oncology

Infectious Diseases

Cardiovascular Diseases

Neurological Disorders

Others

By Technology

Digital Imaging

Analog Imaging

Hybrid Imaging

Others

By Distribution Channel

Direct Sales

Distributors

Online Sales

Others

By Region

New South Wales

Victoria

Queensland

Western Australia

South Australia

Tasmania

Others

By Patient Demographics

Pediatric Patients

Adult Patients

Geriatric Patients

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Therapeutic Goods Administration, Australian Competition and Consumer Commission)

Manufacturers and Producers of Imaging Equipment

Healthcare Providers and Hospitals

Medical Imaging Service Providers

Health Insurance Companies

Industry Associations (e.g., Medical Technology Association of Australia)

Pharmaceutical Companies involved in Infectious Disease Treatment

Players Mentioned in the Report:

Siemens Healthineers

GE Healthcare

Philips Healthcare

Canon Medical Systems

Fujifilm Medical Systems

Hitachi Medical Corporation

Agfa HealthCare

Carestream Health

Hologic, Inc.

Mindray Medical International Limited

Varian Medical Systems

Toshiba Medical Systems

Samsung Medison

Bracco Imaging

Neusoft Medical Systems

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Australia Infections Imaging Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Australia Infections Imaging Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Australia Infections Imaging Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of infectious diseases
3.1.2 Advancements in imaging technology
3.1.3 Rising healthcare expenditure
3.1.4 Growing demand for early diagnosis

3.2 Market Challenges

3.2.1 High cost of imaging equipment
3.2.2 Limited access in rural areas
3.2.3 Regulatory hurdles
3.2.4 Shortage of trained professionals

3.3 Market Opportunities

3.3.1 Expansion of telemedicine
3.3.2 Integration of AI in imaging
3.3.3 Collaborations with research institutions
3.3.4 Development of portable imaging devices

3.4 Market Trends

3.4.1 Shift towards minimally invasive procedures
3.4.2 Increased focus on patient-centric care
3.4.3 Adoption of cloud-based imaging solutions
3.4.4 Growing emphasis on preventive healthcare

3.5 Government Regulation

3.5.1 Compliance with Australian Radiation Protection and Nuclear Safety Agency (ARPANSA)
3.5.2 Therapeutic Goods Administration (TGA) regulations
3.5.3 Medicare funding policies
3.5.4 Health Technology Assessment (HTA) guidelines

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Australia Infections Imaging Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Australia Infections Imaging Market Segmentation

8.1 By Type

8.1.1 X-ray Imaging
8.1.2 MRI Imaging
8.1.3 CT Scans
8.1.4 Ultrasound Imaging
8.1.5 PET Scans
8.1.6 Nuclear Medicine Imaging
8.1.7 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Diagnostic Imaging Centers
8.2.3 Research Institutions
8.2.4 Outpatient Facilities
8.2.5 Others

8.3 By Application

8.3.1 Oncology
8.3.2 Infectious Diseases
8.3.3 Cardiovascular Diseases
8.3.4 Neurological Disorders
8.3.5 Others

8.4 By Technology

8.4.1 Digital Imaging
8.4.2 Analog Imaging
8.4.3 Hybrid Imaging
8.4.4 Others

8.5 By Distribution Channel

8.5.1 Direct Sales
8.5.2 Distributors
8.5.3 Online Sales
8.5.4 Others

8.6 By Region

8.6.1 New South Wales
8.6.2 Victoria
8.6.3 Queensland
8.6.4 Western Australia
8.6.5 South Australia
8.6.6 Tasmania
8.6.7 Others

8.7 By Patient Demographics

8.7.1 Pediatric Patients
8.7.2 Adult Patients
8.7.3 Geriatric Patients
8.7.4 Others

9. Australia Infections Imaging Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Innovation Rate
9.2.8 Operational Efficiency
9.2.9 Brand Recognition
9.2.10 Customer Satisfaction Score

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Siemens Healthineers
9.5.2 GE Healthcare
9.5.3 Philips Healthcare
9.5.4 Canon Medical Systems
9.5.5 Fujifilm Medical Systems
9.5.6 Hitachi Medical Corporation
9.5.7 Agfa HealthCare
9.5.8 Carestream Health
9.5.9 Hologic, Inc.
9.5.10 Mindray Medical International Limited
9.5.11 Varian Medical Systems
9.5.12 Toshiba Medical Systems
9.5.13 Samsung Medison
9.5.14 Bracco Imaging
9.5.15 Neusoft Medical Systems

10. Australia Infections Imaging Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation Trends
10.1.2 Decision-Making Processes
10.1.3 Preferred Suppliers
10.1.4 Contracting Practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment Trends
10.2.2 Funding Sources
10.2.3 Project Prioritization
10.2.4 Cost Management Strategies

10.3 Pain Point Analysis by End-User Category

10.3.1 Equipment Availability
10.3.2 Service Quality
10.3.3 Training Needs
10.3.4 Technology Integration

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Training Programs
10.4.3 Infrastructure Readiness
10.4.4 Support Services

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Performance Metrics
10.5.2 User Feedback
10.5.3 Future Investment Plans
10.5.4 Case Studies

11. Australia Infections Imaging Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Value Proposition Development

1.3 Revenue Streams

1.4 Cost Structure

1.5 Key Partnerships

1.6 Customer Segments

1.7 Channels


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of published reports from Australian health authorities and organizations
  • Review of academic journals and articles focusing on infection imaging technologies
  • Examination of market trends and forecasts from industry publications and white papers

Primary Research

  • Interviews with radiologists and imaging specialists in hospitals and clinics
  • Surveys with medical equipment suppliers and distributors in the infection imaging sector
  • Field interviews with healthcare administrators regarding imaging technology adoption

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including government health statistics
  • Triangulation of insights from primary interviews and secondary data analysis
  • Sanity checks conducted through expert panel reviews comprising industry veterans

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total healthcare expenditure in Australia related to imaging services
  • Segmentation of the market by imaging modalities (e.g., MRI, CT, Ultrasound) and infection types
  • Incorporation of government health initiatives promoting advanced imaging technologies

Bottom-up Modeling

  • Collection of data on unit sales and pricing from leading imaging equipment manufacturers
  • Operational cost analysis based on service delivery models in hospitals and clinics
  • Volume x cost calculations for various imaging services related to infections

Forecasting & Scenario Analysis

  • Multi-factor regression analysis considering population health trends and disease prevalence
  • Scenario modeling based on technological advancements and regulatory changes
  • Baseline, optimistic, and pessimistic projections for the market through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Hospital Imaging Departments150Radiologists, Imaging Technologists
Private Imaging Clinics100Clinic Managers, Radiology Technicians
Healthcare Equipment Suppliers80Sales Managers, Product Specialists
Public Health Organizations60Health Policy Analysts, Epidemiologists
Research Institutions70Medical Researchers, Academic Professors

Frequently Asked Questions

What is the current value of the Australia Infections Imaging Market?

The Australia Infections Imaging Market is valued at approximately USD 1.2 billion, reflecting a significant growth driven by the increasing prevalence of infectious diseases and advancements in imaging technologies.

What factors are driving the growth of the Australia Infections Imaging Market?

Which cities are the primary markets for infections imaging in Australia?

How has the Australian government supported the infections imaging sector?

Other Adjacent Reports

Kuwait Diagnostic Imaging Market

KSA Medical Imaging Equipment Market

Mexico Infectious Disease Diagnostics Market

South Korea Radiology Equipment Market

Belgium Healthcare AI Market

Global Telemedicine Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Mexico Portable Imaging Devices Market

Saudi Arabia Nuclear Medicine Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Singapore Ultrasound Imaging Market

South Korea CT Imaging Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022